Preferred Label : bone density conservation agents;

MeSH definition : Agents that inhibit BONE RESORPTION and/or favor BONE MINERALIZATION and BONE REGENERATION. They are used to heal BONE FRACTURES and to treat METABOLIC BONE DISEASES such as OSTEOPOROSIS.;

MeSH hyponym : antiresorptive agents; Bone Resorption Inhibitors; Inhibitors, Bone Resorption; Resorption Inhibitors, Bone; Bone Resorption Inhibitory Agents; Antiresorptive Drugs; Antiresorptive Agent; Agent, Antiresorptive;

Is substance : O;

action pharmacologique : O;

Details


Main resources

You can consult :

Agents that inhibit BONE RESORPTION and/or favor BONE MINERALIZATION and BONE REGENERATION. They are used to heal BONE FRACTURES and to treat METABOLIC BONE DISEASES such as OSTEOPOROSIS.

http://www.has-sante.fr/portail/jcms/c_1751307/fr/les-medicaments-de-losteoporose
2023
false
true
false
France
French
bone density conservation agents
osteoporosis
treatment outcome
alendronic acid
alendronate
guidelines for drug use
zoledronic acid
administration, oral
risedronic acid
denosumab
Raloxifene Hydrochloride
strontium ranelate
strontium ranelate
teriparatide
teriparatide
spinal fractures
hip fractures
costs and cost analysis
bone density conservation agents
drug costs
bone density
risk
osteoporosis, postmenopausal
adrenal cortex hormones
osteoporosis
osteoporotic fractures
alendronic acid and colecalciferol
drugs, generic
infusions, intravenous
risedronic acid, calcium and colecalciferol, sequential
injections, subcutaneous
raloxifene
algorithms
Adrenocortical steroid therapy
corticosteroid therapy
Risedronic Acid
Denosumab
diphosphonates
imidazoles
organometallic compounds
thiophenes
Zoledronic Acid

---
Medikamentöse Osteoporose-therapie: Behandlungsdauer und Vorgehen nach Therapieende
https://medicalforum.ch/fr/detail/doi/fms.2017.03062/
10.4414/fms.2017.03062
2017
false
false
false
Switzerland
French
German
journal article
osteoporosis, postmenopausal
diphosphonates
bisphosphonates
Denosumab
practice guidelines as topic
denosumab
bone density conservation agents
rank ligand
comparative effectiveness research
teriparatide
teriparatide
Duration of treatment (qualifier value)
osteoporotic fractures
treatment outcome
spinal fractures
guidelines for drug use
bone density
risk
vitamin D
hip fractures
Rebound effect
Therapy cessation
Tumor Necrosis Factor Inhibitors

---
https://pharmacomedicale.org/medicaments/par-specialites/item/autres-medicaments-de-l-osteoporose
2017
France
drug information
osteoporosis
osteoporosis
Osteoporosis
drug-induced osteoporosis
bone density conservation agents
osteoporosis

---
https://dumas.ccsd.cnrs.fr/dumas-01390044
2016
false
true
false
France
French
dissertations, academic
fracture of femur, nos
data collection
bone density conservation agents
superior
residential facilities
institutionalization
fracture, nos
fracture: femur
hip fractures
fracture, nos
case histories
treaties
femoral fractures
prescription, nos
history of (present illness)

---
http://www.sudoc.fr/197078125
2016
false
true
false
France
French
dissertations, academic
treaties
case histories
institutionalization
femur
femoral fractures
therapeutics
bone density conservation agents
data collection
residential facilities
institutionalization
hip fractures
femur
extremities
fractures, bone
femoral fractures
guideline adherence
diphosphonates
international cooperation
case reports

---
http://www.oiiq.org/sites/default/files/uploads/periodiques/Perspective/vol13no01/13-pratique-clinique.pdf
2016
false
false
false
false
Canada
French
journal article
osteoporotic fractures
case reports
risk assessment
osteoporotic fractures
osteoporotic fractures
diphosphonates
bone density conservation agents
adult
absorptiometry, photon
osteoporotic fractures
dietary supplements
osteoporotic fractures

---
http://www.inesss.qc.ca/fileadmin/doc/INESSS/Rapports/Medicaments/INESSS_Portrait_usage_osteoporose.pdf
2014
false
false
false
Canada
French
technical report
adult
aged
diphosphonates
osteoporotic fractures
alendronate
bone density conservation agents
imidazoles
medication adherence
vitamin D
calcium
calcium, dietary
osteoporosis
Risedronic Acid
Denosumab
Zoledronic Acid

---
http://www.cfp.ca/content/60/4/e197.full
2014
Canada
French
osteoporosis
diphosphonates
journal article
osteoporotic fractures
case reports
bone density conservation agents
diphosphates
bone density conservation agents
Bisphosphonate-Associated osteonecrosis of the jaw
femoral fractures
retreatment
drug administration schedule
Therapy cessation

---
http://www.cochrane.org/fr/CD002010
2013
United Kingdom
France
French
meta-analysis
cystic fibrosis
diphosphonates
osteoporosis
treatment outcome
bone density conservation agents
french abstract

---
http://www.has-sante.fr/portail/jcms/c_1701315/fr/zometa
http://www.has-sante.fr/portail/jcms/c_1701314/fr/zometa06112013avisct12958
http://www.has-sante.fr/portail/jcms/c_981921/fr/zometa
http://www.has-sante.fr/portail/jcms/c_399784/fr/zometa-4-mg-poudre-et-solvant-pour-solution-pour-perfusion-boite-de-1
http://www.has-sante.fr/portail/jcms/c_399290/fr/zometa-4-mg-poudre-et-solvant-pour-solution-pour-perfusion-boite-de-1-4-et-10?xtmc=&xtcr=4
2013
France
French
evaluation of the transparency committee
bone density conservation agents
diphosphonates
imidazoles
zoledronic acid
infusions, intravenous
insurance, health, reimbursement
neoplasms
hypercalcemia
adult
bone neoplasms
bone neoplasms
fractures, spontaneous
spinal cord compression
Zoledronic Acid

---
https://www.ema.europa.eu/medicines/human/EPAR/Zometa
2013
United Kingdom
English
French
syndication feed
drug evaluation
diphosphonates
imidazoles
bone density conservation agents
hypercalcemia
bone neoplasms
treatment outcome
imidazoles
diphosphonates
bone density conservation agents
bone resorption
zoledronic acid
diphosphonates
neoplasms
drug evaluation
summary of product characteristics
package leaflet
fractures, spontaneous
spinal cord compression
hypercalcemia
Zoledronic Acid

---
https://www.ema.europa.eu/medicines/human/EPAR/Forsteo
2012
United Kingdom
French
English
syndication feed
Adrenocortical steroid therapy
Glucocorticoid therapy
corticosteroid therapy
osteoporosis
osteoporosis
osteoporotic fractures
glucocorticoids
osteoporosis, postmenopausal
teriparatide
teriparatide
bone density conservation agents
bone density conservation agents
treatment outcome
drug evaluation
drug approval
drug labeling
spinal fractures
injections, subcutaneous
drug interactions
drug evaluation, preclinical
drug storage
teriparatide
drug evaluation
summary of product characteristics
package leaflet

---
http://www.cochrane.org/fr/CD001155
2011
United Kingdom
France
French
meta-analysis
osteoporosis, postmenopausal
osteoporotic fractures
alendronate
treatment outcome
bone density conservation agents
french abstract

---
http://www.cbip.be/pdf/tft/TF_Osteop.pdf
2011
Belgium
French
Adrenocortical steroid therapy
Glucocorticoid therapy
corticosteroid therapy
osteoporosis
glucocorticoids
osteoporosis
treatment outcome
osteoporosis
bone density conservation agents
diphosphonates
alendronate
guideline

---
http://www.cochrane.org/fr/CD005324
2010
United Kingdom
France
French
meta-analysis
osteoporosis
child
adolescent
diphosphonates
treatment outcome
bone density conservation agents
osteoporosis
french abstract

---
http://www.cochrane.org/fr/CD000952
2010
United Kingdom
France
French
Adrenocortical steroid therapy
corticosteroid therapy
meta-analysis
vitamin D
calcium
osteoporosis
adrenal cortex hormones
osteoporosis
bone density conservation agents
french abstract

---
http://www.cochrane.org/fr/CD001347
2010
United Kingdom
France
French
Adrenocortical steroid therapy
corticosteroid therapy
meta-analysis
osteoporosis
adrenal cortex hormones
osteoporosis
diphosphonates
treatment outcome
bone density conservation agents
osteoporosis
french abstract

---
http://www.cochrane.org/fr/CD001983
2010
United Kingdom
France
French
Adrenocortical steroid therapy
Glucocorticoid therapy
corticosteroid therapy
review of literature
osteoporosis
osteoporosis
calcitonin
glucocorticoids
treatment outcome
bone density conservation agents
osteoporosis
french abstract

---
http://www.cochrane.org/fr/CD006944
2010
United Kingdom
France
French
meta-analysis
child
bone density
vitamin D
dietary supplements
bone density conservation agents
french abstract

---
https://medicalforum.ch/fr/detail/doi/fms.2010.07259/
2010
false
Switzerland
French
Cancer Pain Management
Cancer Pain
Cancer Pain
Cancer pain
diphosphonates
bone density conservation agents
bone neoplasms
bone neoplasms
pain
journal article
practice guideline

---
http://www.has-sante.fr/portail/jcms/c_841406/cadens-calsyn-cibacalcine-miacalcic-calcitonine-pharmy-ii-calcitonine-sandoz-calcitonines-humaine-ou-de-saumon-injectables
http://www.has-sante.fr/portail/jcms/c_818073/calcitonine-sandoz-ct-6883
http://www.has-sante.fr/portail/jcms/c_818043/calcitonine-pharmy-ii-ct-4148
http://www.has-sante.fr/portail/jcms/c_818018/cadens-ct-5379
http://www.has-sante.fr/portail/jcms/c_817960/calsyn-ct-5321
http://www.has-sante.fr/portail/jcms/c_817969/cibacalcine-ct-6811
http://www.has-sante.fr/portail/jcms/c_818088/miacalcic-ct-6064
2009
France
French
osteitis deformans
hypercalcemia
bone density conservation agents
calcitonin
salmon calcitonin
calcitonin preparations
calcitonin
evaluation of the transparency committee
guidelines for drug use

---
https://www.has-sante.fr/jcms/r_1439939
2008
true
France
French
diphosphonates
imidazoles
bone density conservation agents
osteoporosis, postmenopausal
injections, intravenous
zoledronic acid
guidelines for drug use
Zoledronic Acid
Zoledronic Acid

---
https://www.minerva-ebp.be/fr/article/589
2007
false
false
minerva-ebm.be
Belgium
French
comparative study
bone density
bone density conservation agents
alendronate
osteoporosis, postmenopausal
treatment outcome
critical appraisal or critical reading

---
https://www.minerva-ebp.be/fr/article/695
2006
false
false
minerva-ebm.be
Belgium
French
osteoporosis, postmenopausal
breast neoplasms
bone density conservation agents
estrogen antagonists
selective estrogen receptor modulators
fractures, bone
treatment outcome
Raloxifene Hydrochloride
critical appraisal or critical reading

---
https://www.minerva-ebp.be/fr/article/709
2006
false
false
minerva-ebm.be
Belgium
French
fractures, bone
vitamin D
dietary supplements
aged
treatment outcome
bone density conservation agents
critical appraisal or critical reading

---
https://rmlg.uliege.be/article/1495
2006
Belgium
French
drug administration schedule
bone density conservation agents
diphosphonates
bone density conservation agents
osteoporosis, postmenopausal
medication adherence
diphosphonates
journal article
Ibandronic Acid

---
https://www.cadth.ca/sites/default/files/pdf/108_No44_teriparatide_edrug_f.pdf
2003
Canada
French
bone density conservation agents
teriparatide
osteoporosis
united states
controlled clinical trials as topic
canada
teriparatide
drug evaluation

---
Nous contacter.
19/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.